keyword
https://read.qxmd.com/read/38391538/clinical-effectiveness-of-continuous-infusion-flucloxacillin-in-the-outpatient-parenteral-antimicrobial-therapy-opat-setting-in-a-uk-hospital-a-service-evaluation
#21
JOURNAL ARTICLE
Annette Margaret Clarkson, Susan Snape
The availability of stability data for the use of continuous intravenous flucloxacillin in an elastomeric device has enabled the treatment of serious Methicillin Sensitive Staphylococcus aureus (MSSA) in the outpatient parenteral antimicrobial therapy (OPAT) setting. This service review aimed to evaluate current standard of care to establish the clinical effectiveness and complication rates associated with its use since its introduction at our institution. A retrospective review of clinical outcomes and adverse events/complications, was undertaken for all patients who received continuous infusion flucloxacillin for complicated MSSA infection between January 2019 and July 2022 via our OPAT service...
February 3, 2024: Antibiotics
https://read.qxmd.com/read/38376128/australian-experience-with-ibrutinib-in-patients-with-relapsed-refractory-mantle-cell-lymphoma-a-study-from-the-lymphoma-and-related-diseases-registry
#22
JOURNAL ARTICLE
Diva Baggio, Cameron Wellard, Eliza Chung, Dipti Talaulikar, Colm Keane, Stephen Opat, Pratyush Giri, Adrian Minson, Chan Yoon Cheah, Tasman Armytage, Denise Lee, Geoffrey Chong, Anna Johnston, Tara Cochrane, Neil Waters, Nada Hamad, Erica M Wood, Eliza A Hawkes
Bruton's tyrosine kinase inhibitors (BTKi) have an established role in the management of patients with relapsed/refractory mantle cell lymphoma (MCL). However, scant data exist on outcomes of patients ineligible for clinical trials testing these therapies. We describe a contemporary cohort of relapsed/refractory MCL patients from the Australasian Lymphoma and Related Diseases Registry treated with ibrutinib December 2014 until July 2018, to determine the proportion potentially eligible for original trials, reasons for ineligibility and survival outcomes...
March 2023: Leukemia & Lymphoma
https://read.qxmd.com/read/38356783/we-shape-our-tools-and-then-our-tools-shape-us-opat-and-the-ehr
#23
EDITORIAL
Christina G Rivera
A commentary on Canterino et al. (2024) and Munsiff et al. (2024), articles where clinicians from two large OPAT programs.
February 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38352154/one-if-by-hand-two-if-orally-piccing-the-best-treatment-option
#24
EDITORIAL
Monica V Mahoney, Christina F Yen
No abstract text is available yet for this article.
February 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38352150/outcomes-of-ceftriaxone-compared-with-cefazolin-or-nafcillin-oxacillin-for-outpatient-therapy-for-methicillin-sensitive-staphylococcus-aureus-bloodstream-infections-results-from-a-large-united-states-claims-database
#25
Yasir Hamad, Katelin B Nickel, Margaret A Olsen, Ige A George
BACKGROUND: Ceftriaxone is a convenient option for methicillin-sensitive Staphylococcus aureus (MSSA) outpatient parenteral antimicrobial therapy (OPAT), but population-based studies for its effectiveness are lacking. METHODS: In this retrospective cohort, a large insurance claims database was queried from 2010 to 2018 for adults with MSSA bloodstream infection (BSI). Patients discharged on OPAT on cefazolin or oxacillin/nafcillin were compared with ceftriaxone with respect to 90-day hospital readmission with the same infection category and 90-day all-cause readmission using logistic regression models...
February 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38343334/off-site-facilities-friend-or-foe-of-outpatient-parenteral-antimicrobial-therapy-opat
#26
JOURNAL ARTICLE
Kelsey L Jensen, Amy Van Abel, Paul Frykman, Christina G Rivera
No abstract text is available yet for this article.
February 12, 2024: Infection Control and Hospital Epidemiology
https://read.qxmd.com/read/38328266/successful-outpatient-parenteral-antibiotic-therapy-with-cefiderocol-for-osteomyelitis-caused-by-multi-drug-resistant-gram-negative-bacteria-a-case-report
#27
JOURNAL ARTICLE
Paul Schellong, Janett Wennek-Klose, Christian Spiegel, Jürgen Rödel, Stefan Hagel
OBJECTIVES: Post-traumatic osteomyelitis attributed to metallo-β-lactamase (MBL)-producing Gram-negative bacteria presents a challenging clinical scenario. Cefiderocol emerges as a viable treatment option within the limited therapeutic options available. PATIENT/CASE DESCRIPTION: In this brief report, we present a case of a Ukrainian patient with osteomyelitis caused by multi-drug resistant Pseudomonas aeruginosa , which was successfully treated with cefiderocol, facilitated in part by outpatient parenteral antibiotic therapy (OPAT)...
February 2024: JAC-antimicrobial resistance
https://read.qxmd.com/read/38315878/biomarker-analysis-of-the-aspen-study-comparing-zanubrutinib-to-ibrutinib-in-patients-with-waldenstr%C3%A3-m-macroglobulinemia
#28
JOURNAL ARTICLE
Constantine S Tam, Stephen Opat, Shirley P D'Sa, Wojciech Jurczak, Hui-Peng Lee, Gavin Cull, Roger G Owen, Paula Marlton, Björn E Wahlin, Ramon Garcia-Sanz, Helen McCarthy, Stephen P Mulligan, Alessandra Tedeschi, Jorge J Castillo, Jaroslaw Czyz, Carlos Fernández de Larrea, David Belada, Edward N Libby, Jeffrey V Matous, Marina Motta, Tanya Siddiqi, Monica Tani, Marek Trněný, Monique C Minnema, Christian Buske, Véronique Leblond, Steven P Treon, Judith Trotman, Binghao Wu, Yiling Yu, Zhirong Shen, Wai Y Chan, Jingjing Schneider, Heather Allewelt, Aileen Cohen, Meletios-Athanasios A Dimopoulos
The phase 3 ASPEN trial (NCT03053440) compared Bruton tyrosine kinase inhibitors (BTKi), zanubrutinib and ibrutinib, in patients with Waldenström macroglobulinemia (WM). Post-hoc biomarker analysis was performed using next-generation sequencing on pretreatment bone marrow samples from 98 zanubrutinib-treated and 92 ibrutinib-treated patients with mutated (MUT) MYD88 and 20 zanubrutinib-treated patients with wild-type (WT) MYD88. Of 329 mutations in 52 genes, mutations in CXCR4 (25.7%), TP53 (24.8%), ARID1A (15...
February 5, 2024: Blood Advances
https://read.qxmd.com/read/38290477/attitudes-towards-covid-19-vaccination-in-adults-with-haematological-malignancies
#29
JOURNAL ARTICLE
Richard Blennerhassett, Nada Hamad, Lisa Grech, Alastair Kwok, Tammie Choi, Cecily Forsyth, Jacqueline Jagger, Stephen Opat, Sam Harris, Bryan Anthony Chan, Mike Nguyen, Nathan Bain, Daphne Day, Eva Segelov
INTRODUCTION: Despite people with haematological malignancies being particularly vulnerable to severe COVID-19 infection and complications, vaccine hesitancy may be a barrier to optimal vaccination. This study explored attitudes towards COVID-19 vaccination in people with haematological malignancies. METHODS: People with haematological malignancies at nine Australian health services were surveyed between June and October, 2021. Sociodemographic and clinical characteristics were collected...
January 30, 2024: Acta Haematologica
https://read.qxmd.com/read/38230930/stability-of-meropenem-in-portable-elastomeric-infusion-devices-which-protocol-should-be-implemented-in-clinical-practice
#30
JOURNAL ARTICLE
Beatriz Esteban-Cartelle, Dolores R Serrano, Covadonga Pérez Menéndez-Conde, Noelia Vicente-Oliveros, Ana Álvarez-Díaz, Jesús Fortún Abete, Pilar Martín-Dávila
Although outpatient parenteral antibiotic therapy can be a good approach to treating infections, a lack of data regarding antibiotic stability in portable elastomeric infusion devices restricts its safe and effective use. Actually, meropenem is used for prolonged periods above 24 h, and it is not physicochemically stable, which can compromise efficacy and toxicity. This work is of high importance to show the clinicians the real shelf life of meropenem when administered in portable elastomeric infusion devices...
January 17, 2024: Microbiology Spectrum
https://read.qxmd.com/read/38227054/the-success-rate-and-complications-of-midline-catheters-in-pediatric-outpatient-parenteral-antibiotic-therapy-opat
#31
JOURNAL ARTICLE
Urban Fläring, Henrik Lundevall, Åke Norberg, Andreas Andersson
The use of outpatient parenteral antimicrobial therapy (OPAT) for children has several advantages, including reduced length of hospital stay and costs. A reliable vascular access is key to delivering safe and effective pediatric OPAT. In recent years, midline catheters (MC) have been increasingly used for short-term intravenous antibiotic therapy in children. However, there are no studies investigating the use of MCs in the OPAT setting. The main aim of this paper was to evaluate the success and complications of using MCs for pediatric OPAT...
January 16, 2024: European Journal of Pediatrics
https://read.qxmd.com/read/38221991/enhanced-production-of-bacteriocin-by-bacillus-subtilis-zy05
#32
JOURNAL ARTICLE
Kumari Chandrika, Ashish Sachan
Bacteriocin-producing strains were isolated from the soil of the rice field, screened out using an agar-well diffusion assay against six indicator bacterial strains, and the highest among them was selected for further investigation. The study focuses on how different growing conditions affect bacteriocin production. One-parameter-at-a-time (OPAT) and a central composite design of response surface methodology (RSM) were used to perform the optimization in two steps. In the OPAT trials, bacteriocin synthesis was elevated by 29%, 45%, and 34%, by employing sucrose as a carbon source and changing the NaCl concentration and pH at 7, respectively...
February 2024: 3 Biotech
https://read.qxmd.com/read/38214417/rethinking-the-transfusion-pathway-in-myelodysplastic-syndromes-study-protocol-for-a-novel-randomized-feasibility-n-of-1-trial-of-weekly-interval-red-cell-transfusion-in-myelodysplastic-syndromes
#33
JOURNAL ARTICLE
Allison Mo, Erica Wood, Jake Shortt, Andrew Charlton, Dorothea Evers, Marlijn Hoeks, Elizabeth Pritchard, James Daly, Carol Hodgson, Stephen Opat, David Bowen, John Reynolds, Le Thi Phung Thao, Simon J Stanworth, Zoe McQuilten
BACKGROUND: Anemia in myelodysplastic syndromes (MDS) is associated with poorer health-related quality of life (HRQoL) and physical function, and is frequently treated with transfusions. The current common practice of transfusing multiple red blood cells (RBC) units every 2-4 weeks may result in peaks/troughs in hemoglobin (Hb) level, yet maintaining a stable Hb may better improve HRQoL. We describe a study protocol aiming to investigate the feasibility of weekly low-dose RBC transfusion in MDS patients, including assessing HRQoL and physical function outcomes...
February 2024: Transfusion
https://read.qxmd.com/read/38178876/cost-evaluation-of-a-nurse-coordinated-outpatient-parenteral-antimicrobial-therapy-opat-program
#34
JOURNAL ARTICLE
Huiwen Deng, Alan E Gross, Andrew B Trotter, Daniel R Touchette
A structured, nurse-driven outpatient parenteral antimicrobial therapy (OPAT) program within an academic healthcare system was associated with reduced odds of 60-day unplanned OPAT readmissions and costs after hospital discharge. These findings may facilitate justifying additional resources for OPAT programs to improve care while decreasing costs.
2024: Antimicrob Steward Healthc Epidemiol
https://read.qxmd.com/read/38165594/experience-with-dalbavancin-use-in-various-gram-positive-infections-within-aberdeen-royal-infirmary-opat-service
#35
JOURNAL ARTICLE
James C McSorley, Darshini Reyes, Ivan Tonna, Vhairi Bateman
PURPOSE: Dalbavancin, approved in 2014 for Gram-positive acute bacterial skin and skin structure infections (ABSSSI), has pharmacokinetics enabling treatment with one or two doses. Dalbavancin might be useful in outpatient parenteral antibiotic therapy (OPAT) of deep-seated infections, otherwise requiring inpatient admission. We documented our experience with pragmatic dalbavancin use to assess its effectiveness for varied indications, on- and off-label, as primary or sequential consolidation therapy...
January 2, 2024: Infection
https://read.qxmd.com/read/38163877/supportive-care-needs-of-adults-living-with-a-peripherally-inserted-central-catheter-picc-at-home-a-qualitative-content-analysis
#36
JOURNAL ARTICLE
Rebecca Sharp, Qunyan Xu, Robyn Pumpa, Lisa Elliott, Nadia Corsini, Julie Marker, Jodie Altschwager, Alanna Ortmann, Lisa Turner, Lili Jin, Amanda Ullman, Adrian Esterman
BACKGROUND: Peripherally inserted central catheters (PICCs) are common vascular access devices inserted for adults undergoing intravenous treatment in the community setting. Individuals with a PICC report challenges understanding information and adapting to the device both practically and psychologically at home. There is a lack of research investigating the supportive care needs of individuals with a PICC to inform nursing assessment and the provision of additional supports they may require to successfully adapt to life with a PICC...
January 2, 2024: BMC Nursing
https://read.qxmd.com/read/38160386/physical-fitness-test-performance-in-firefighter-trainees-differences-between-graduated-and-released-trainees-and-predicting-academy-graduation
#37
JOURNAL ARTICLE
Robert G Lockie, Robin M Orr, Fernando Montes, J Jay Dawes
BACKGROUND: Fitness tests have been previously used to predict academy graduation and highlight specific capacities to be targeted in applicants/trainees to optimise their potential for academy success. OBJECTIVE: To compare the fitness of graduated and released (did not complete academy requirements) firefighter trainees and explore using decision tree analysis to predict academy graduation via fitness tests. METHODS: Retrospective analysis was conducted on 686 trainees who completed an occupational physical ability test (OPAT): Illinois agility test; push-ups; pull-ups; leg tucks; estimated maximal aerobic capacity (VO2max); backwards overhead 4...
December 28, 2023: Work: a Journal of Prevention, Assessment, and Rehabilitation
https://read.qxmd.com/read/38156214/impact-of-a-pharmacist-managed-outpatient-parenteral-antimicrobial-therapy-opat-service-on-cost-savings-and-clinical-outcomes-at-an-academic-medical-center-addendum
#38
JOURNAL ARTICLE
Taylor M Epperson, Kiya K Bennett, Katherine K Kupiec, Kathy Speigel, Stephen B Neely, Beth H Resman-Targoff, Karen K Kinney, Bryan P White
No abstract text is available yet for this article.
2023: Antimicrob Steward Healthc Epidemiol
https://read.qxmd.com/read/38156049/first-generation-cephalosporins-for-treatment-of-acute-hematogenous-osteomyelitis-in-children-a-study-of-efficacy-and-adverse-effects
#39
JOURNAL ARTICLE
Lisa Hiskey, Hiba Saifuddin, Emily R Levy, Roland Hentz, Nipunie S Rajapakse, Laura M Dinnes, Elizabeth H Ristagno
BACKGROUND: Acute hematogenous osteomyelitis (AHO) is a relatively infrequent but significant infection in pediatric patients. As Staphylococcus aureus is the most common cause of AHO, intravenous and oral first-generation cephalosporins are common therapies. Cephalexin is a commonly prescribed oral therapy for pediatric AHO, although it requires frequent dosing that may affect adherence. Cefadroxil is a comparable oral first-generation cephalosporin with a more desirable dosing schedule...
December 2023: Open Forum Infectious Diseases
https://read.qxmd.com/read/38140046/stability-studies-of-antipseudomonal-beta-lactam-agents-for-outpatient-therapy
#40
JOURNAL ARTICLE
Beatriz Fernández-Rubio, Laura Herrera-Hidalgo, Arístides de Alarcón, Rafael Luque-Márquez, Luis E López-Cortés, Sònia Luque, José María Gutiérrez-Urbón, Aurora Fernández-Polo, Alicia Gutiérrez-Valencia, María V Gil-Navarro
Outpatient parenteral antimicrobial therapy (OPAT) is a useful treatment strategy against Pseudomonas aeruginosa and other multidrug-resistant bacteria. However, it is hindered by the lack of stability data for the administration of antibiotics under OPAT conditions. Our objective was to investigate the stability of nine antipseudomonal and broad-spectrum beta lactam antibiotics (aztreonam, cefepime, cefiderocol, ceftazidime, ceftazidime/avibactam, ceftolozane/tazobactam, meropenem, meropenem/vaborbactam, and piperacillin/tazobactam) to allow the spread of OPAT programs...
November 30, 2023: Pharmaceutics
keyword
keyword
55881
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.